Cellcept Related Clinical Trials
A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . . [Terminated]
A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS. [Terminated]
Myfortic vs. Cellcept in Kidney Transplant Recipients [Completed]
Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation [Completed]
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis. [Active, not recruiting]
A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-Coated Mycophenolate Sodium (EC-MPS) [Completed]
Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients. [Completed]
A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis. [Completed]
Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis [Completed]
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant [Active, not recruiting]
Effects of Mycophenolate Mofetil On Anti-HLA Antibody Levels In Patients Awaiting Cadaveric Renal Transplant [Active, not recruiting]
Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients [Active, not recruiting]
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV) [Active, not recruiting]
Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome [Completed]
Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk [Completed]
Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-Coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapy [Active, not recruiting]
A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients [Completed]
Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-Coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus [Active, not recruiting]
A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes. [Active, not recruiting]
Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept [Terminated]
Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver Transplantation [Active, not recruiting]
A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis. [Completed]
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis [Completed]
Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-Coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal Transplant [Active, not recruiting]
Extension Study to Assess Tolerability and Safety of Enteric-Coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil [Active, not recruiting]
CellCept® (Mycophenolate Mofetil) in Pemphigus Vulgaris
Study of Enteric-Coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients [Completed]
CellCept® (Mycophenolate Mofetil) in Myasthenia Gravis, Optional Double-Blind Treatment Continuation of Protocol WX17798 [Recruiting]
Study of Gastrointestinal Side Effects in African American Kidney Transplant Recipients Treated With CellCept or Myfortic [Recruiting]
Follow-up Study of Safety of Enteric-Coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301 [Active, not recruiting]
Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis [Recruiting]
Pilot Study of Mycophenolate Mofetil in Congenital Uropathies [Completed]
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients. [Recruiting]
Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients [Terminated]
Adjunct CellCept (Mycophenolate Mofetil) With Reduced Corticosteroids in Subjects With Myasthenia Gravis [Completed]
CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients [Not yet recruiting]
Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients [Recruiting]
Gastrointestinal and Health-Related Quality of Life in Kidney Transplant Patients Treated With Mycophenolate Mofetil [Recruiting]
A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors [Recruiting]
Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute GVHD [Recruiting]
A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients. [Recruiting]
A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients. [Recruiting]
Sirolimus and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis in Myeloablative Matched Related Donor Hematopoietic Cell Transplant [Active, not recruiting]
Combination Therapy Using Cellcept and Rebif in RRMS [Recruiting]
Effects of Rituximab and Mycophenolate Mofetil on Anti-Donor Antibody Production in Patients Awaiting Transplant [Recruiting]
Mycophenolate Mofetil in Membranous Nephropathy [Completed]
Mycophenolate for Pulmonary Sarcoidosis [Terminated]
Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients [Recruiting]
Conversion From Mycophnolate Mofetil to Mycophenolate Sodium in Renal Transplant [Not yet recruiting]
Gastrointestinal and Health-Related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate [Recruiting]
Trial of Mycophenolate Mofetil in Myasthenia Gravis [Recruiting]
Follow-Up Study of Safety of Enteric-Coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107 [No longer recruiting]
Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis [Recruiting]
New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial [Active, not recruiting]
Extension Study of Enteric-Coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With De Novo Kidney Transplants [No longer recruiting]
CYA Versus MMF for Treatment of Moderate-Severe Psoriasis. [Active, not recruiting]
Follow-Up Study of Safety of Enteric-Coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302 [No longer recruiting]
Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation [Not yet recruiting]
Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN) [Recruiting]
Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation [Recruiting]
Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA) [Recruiting]
Enteric-Coated Mycophenolate Sodium (Myfortic®) in Heart Transplant Recipients [Recruiting]
A Study Comparing Corticosteroid Withdrawal to Continuation in Kidney Transplantation With Thymoglobulin Induction, Mycophenolate Mofetil and Tacrolimus Based-Immunosuppression [Recruiting]
Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil [Recruiting]
CellCept in p-ANCA Vasculitis [Recruiting]
Velcade for High Immunological Risk Kidney Transplant Recipients [Recruiting]
Enteric-Coated Mycophenolate Sodium (EC-MPS) With Reduced-Dose Tacrolimus Versus EC-MPS With Standard-Dose Tacrolimus in Stable Kidney Transplant Recipients [Recruiting]
Immunosuppressive Treatment Regimens With or Without Mycophenolate Mofetil in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease [Recruiting]
Pharmacokinetics of Mmf and Valganciclovir [Recruiting]
Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid [Completed]
Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment [Terminated]
Conversion of CellCept to Myfortic: A Prospective Study in Liver Transplant Recipients [Recruiting]
Enteric-Coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With GI Intolerance [Recruiting]
Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement [Recruiting]
Extension Study on the Efficacy and Safety of Enteric-Coated Mycophenolate Sodium Administered in De Novo Kidney Transplant Patients [No longer recruiting]
Evaluation of the Therapeutic Benefit of an Initial Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Regimen in Renal Transplant Patients [Recruiting]
Single or Double Umbilical Cord Blood Unit Transplantation Followed by GVHD Prophylaxis With FK506 and MMF [Recruiting]
A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients [Recruiting]
CellCept/Iron Study: The Iron Ion-Mycophenolate Mofetil Chelation Complex Interaction in Renal Allograft Recipients [Completed]
Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis. [Recruiting]
Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis [Recruiting]
Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [Active, not recruiting]
A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis [Recruiting]
Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients [Completed]
To Compare the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis [Recruiting]
Etanercept, Mycophenolate Mofetil, Denileukin Diftitox, or Pentostatin Combined With Prednisone or Methylprednisolone in Treating Patients With Acute Graft-Versus-Host Disease Who Have Undergone a Previous Donor Stem Cell Transplant [Recruiting]
Immunosuppression With Mycophenolate Mofetil and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies or Metastatic Renal Cell Carcinoma [No longer recruiting]
Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX [Recruiting]
A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-Coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms [Recruiting]
Comparison of Alemtuzumab/Tacrolimus Versus Interleukin-2 Receptor (IL-2R) Monoclonal Antibody (MoAb)/Tacrolimus/Mycophenolate in Kidney Transplantation [Active, not recruiting]
Efficacy and Safety of Enteric-Coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare [Recruiting]
Concentration Controlled Everolimus With Reduced Dose Neoral® Versus Mycophenolate Mofetil With Standard Dose Neoral® in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids [Recruiting]
Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Micoemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients [Recruiting]
Efficacy and Safety of Enteric-Coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients [Recruiting]
Extension Study of Enteric-Coated Mycophenolate Sodium With Short-Term or No Steroid Use Compared With Enteric-Coated Mycophenolate Sodium With Standard Steroid Therapy in De Novo Kidney Recipients [No longer recruiting]
Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients [No longer recruiting]
Study Evaluating Sirolimus in Kidney Transplant Recipients [Active, not recruiting]
Rapamycin vs Mycophenolate Mofetil in Kidney-Pancreas Recipients [Recruiting]
Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-Free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients [Active, not recruiting]
Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental [Recruiting]
Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant [No longer recruiting]
|
